Global Nanotechnology Drug Delivery Market Size (2024 - 2029)

The nanotechnology drug delivery market is experiencing growth driven by the increasing demand for advanced medication delivery systems, particularly highlighted during the COVID-19 pandemic. The effectiveness of nanoparticle-based formulations in treating COVID-19 has spurred interest and investment in this sector. Additionally, the rising prevalence of chronic diseases such as diabetes and cancer is fueling the need for targeted drug delivery solutions, further contributing to the market's expansion. Advancements in nanoscale technologies and ongoing research and development efforts are also supporting market growth. However, the high cost of nanotechnology drug delivery systems and stringent regulatory requirements pose challenges to the market's expansion.

Home Market Analysis Healthcare Research Device Drug Combination Research Drug Filled Devices Research Targeted Liposomes Drug Delivery Industry Market Size

Market Size of Global Nanotechnology Drug Delivery Industry

nanotechnology drug delivery market size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 8.30 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Global Nanotechnology Drug Delivery Market Major Players

*Disclaimer: Major Players sorted in no particular order

Nanotechnology Drug Delivery Market Analysis

The nanotechnology drug delivery market is poised to grow at a CAGR of 8.3% over the forecast period.

During the covid-19 pandemic, most pharmaceutical companies and governments were attempting to provide effective medical treatment to covid-19 patients, and medication delivery systems were expected to play an important role in this context. The use of nanoparticles for the treatment of COVID-19 increased. The use of drug delivery devices and systems increased, as nanoparticle drug formulations play a vital role in pulmonary drug delivery. The article published in November 2021, titled 'Nanoparticles as an effective drug delivery system in COVID-19', stated that nanomedicines and nano drug delivery systems and devices show effectiveness against COVID-19 as treatments. The ongoing research on the effectiveness of nanotechnology drug delivery in the treatment of COVID-19 boosted the market and drove the growth of the market studied, during the pandemic.

The rising prevalence of chronic diseases and illnesses such as diabetes, cancer, and cardiovascular disease has increased the demand for innovative medications with targeted delivery for various chronic diseases. The prevalence of diabetes among the global population is drastically increasing. According to the data published by the International Diabetes Federation (IDF) Diabetes Atlas Tenth Edition 2021, in the year 2021, approximately 537 million adults (aged 20-79 years) were living with diabetes. The same source estimated that the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The rising burden of diabetes is likely to increase the demand for more technically advanced drug delivery options for treatment and diagnosis. Additionally, according to the Global Cancer Observatory (Globocan) Statistics 2020, there are 19.3 million new cases of cancer all over the world, accounting for both sexes in 2020. The same source reports that the incidence of cancer is growing at a rapid pace in the world and estimates that the number of new cases of cancer in both sexes will reach 28.8 million by 2040. Hence, the rising prevalence of chronic diseases creates demand for nanotechnology drug delivery systems, thereby boosting market growth.

Moreover, increasing advancements in nanoscale technologies and research and development activities have also supported the growth of the market. For instance, in July 2022, the EU Horizon 2020 B-SMART project attempted to create a novel method of delivering RNA through the blood-cerebrospinal fluid barrier, allowing treatments to be delivered directly to the brain. A therapy like this has the potential to enhance the lives of millions of people who suffer from neurodegenerative diseases. Hence, such advancements in nano drug delivery systems propel the growth of the market.

However, the cost of nanotechnology drug delivery medicine and stringent regulations for the mechanism approval have restrained the growth of the market.

Nanotechnology Drug Delivery Industry Segmentation

As per the scope of the report, nanotechnology drug delivery applications occur through the use of designed nanomaterials as well as forming delivery systems from nanoscale molecules. These materials help in improving the bioavailability of the drug. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The Nanotechnology Drug Delivery Market is segmented by Technology (Nanocrystals, Nanoparticles, Liposomes, Micelles, Others), Application (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Technology
Nanocrystals
Nanoparticles
Liposomes
Micelles
Others
By Application
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Nanotechnology Drug Delivery Market Size Summary

The nanotechnology drug delivery market is experiencing significant growth, driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions. The demand for innovative medications with targeted delivery systems is rising, as these diseases necessitate advanced treatment options. The COVID-19 pandemic further accelerated market expansion, as nanoparticles proved effective in drug delivery systems for treating the virus. Ongoing research and advancements in nanoscale technologies, such as the EU Horizon 2020 B-SMART project, are propelling the market forward by enabling novel delivery methods for treatments, including those for neurodegenerative diseases. Despite the promising growth, challenges such as high costs and stringent regulatory approvals continue to pose constraints on market expansion.

Regionally, North America is expected to witness substantial growth in the nanotechnology drug delivery market, fueled by the rising incidence of chronic diseases like cancer and HIV, along with increased product launches and initiatives by key market players. Technological advancements, such as the development of nanoparticles for targeted therapy, are further supporting market growth. The competitive landscape is characterized by a moderate level of competition, with numerous companies investing in research and development to enhance nanomedicine applications. Collaborations between pharmaceutical companies and technology developers are also on the rise, contributing to the market's steady expansion. Major players in the market include Taiwan Liposome Company, Nanobiotix, Aquanova AG, NanoCarrier Co Ltd, and NanOlogy LLC, all of which are actively involved in developing advanced drug delivery systems.

Explore More

Global Nanotechnology Drug Delivery Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases

      2. 1.2.2 Increasing Advancements in Nanoscale Technologies

      3. 1.2.3 Growing Preference for Personalized Medicines

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Nanotechnology Drug Delivery Technique

      2. 1.3.2 Stringent Regulations for Commercial Introduction

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Technology

      1. 2.1.1 Nanocrystals

      2. 2.1.2 Nanoparticles

      3. 2.1.3 Liposomes

      4. 2.1.4 Micelles

      5. 2.1.5 Others

    2. 2.2 By Application

      1. 2.2.1 Neurology

      2. 2.2.2 Oncology

      3. 2.2.3 Cardiovascular/Physiology

      4. 2.2.4 Anti-inflammatory/Immunology

      5. 2.2.5 Anti-infective

      6. 2.2.6 Other Applications

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Nanotechnology Drug Delivery Market Size FAQs

The Global Nanotechnology Drug Delivery Market is projected to register a CAGR of 8.30% during the forecast period (2024-2029)

Taiwan Liposome Company, Nanobiotix, Aquanova AG, NanoCarrier Co Ltd and NanOlogy LLC are the major companies operating in the Global Nanotechnology Drug Delivery Market.

Nanotechnology Drug Delivery Market Report Snapshots

Nanotechnology Drug Delivery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)